Interações medicamentosas
Elvitegravir / cobicistat / emtricitabine / tenofovir df + Liposomal doxorubicin
Gravidade: Grave
Elvitegravir / cobicistat / emtricitabine / tenofovir df and Liposomal doxorubicin: major interaction.
Última atualização
Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.
O conteúdo clínico desta página está disponível apenas em inglês.
Resumo
Cobicistat inhibits CYP3A4, CYP2D6 and P-glycoprotein, and may increase exposure to doxorubicin released from the liposome. This could worsen myelosuppression, mucositis, hand-foot syndrome and cardiotoxicity.
O que esta interação significa em palavras simples
Elvitegravir / cobicistat / emtricitabine / tenofovir df and Liposomal doxorubicin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Por que acontece
Cobicistat inhibits CYP3A4, CYP2D6 and P-glycoprotein, reducing clearance of doxorubicin.
O que fazer
Prefer an unboosted antiretroviral regimen during therapy. If combined, monitor blood counts, mucocutaneous toxicity and cardiac function, and reduce the doxorubicin dose if toxicity appears.
O que perguntar ao farmacêutico
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Para assinantes do Pro+
Desbloqueie a página completa
Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Elvitegravir / cobicistat / emtricitabine / tenofovir df e Liposomal doxorubicin, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Experimente o Pro+ grátis por 14 dias na web. Sem cartão.
Outras interações de Liposomal doxorubicin
Perguntas frequentes
Can I take Elvitegravir / cobicistat / emtricitabine / tenofovir df with Liposomal doxorubicin?
MediHelp rates the interaction as major. Elvitegravir / cobicistat / emtricitabine / tenofovir df and Liposomal doxorubicin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Cobicistat inhibits CYP3A4, CYP2D6 and P-glycoprotein, and may increase exposure to doxorubicin released from the liposome. This could worsen myelosuppression, mucositis, hand-foot syndrome and cardiotoxicity.
How serious is the interaction between Elvitegravir / cobicistat / emtricitabine / tenofovir df and Liposomal doxorubicin?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer an unboosted antiretroviral regimen during therapy. If combined, monitor blood counts, mucocutaneous toxicity and cardiac function, and reduce the doxorubicin dose if toxicity appears.
What other medicines interact with Liposomal doxorubicin?
MediHelp also lists interactions of Liposomal doxorubicin with, for example, Dengue vaccine, Belatacept, Cyclosporine. The full list is on the Liposomal doxorubicin page.
Monografias completas, posologia e verificador de interações no app MediHelp
Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.
